Radiation Therapy Quality Assurance (QA) Phantoms Market Revenue, Growth, Trends and Forecast Report 2028

The latest industry intelligence research on the Radiation Therapy Quality Assurance (QA) Phantoms market offers a repository of valuable data on the size, share, and growth rate of the Radiation Therapy Quality Assurance (QA) PHANTOMS market for the forecast period, 2020 - 2028. Importantly, examination of various facets of the industry including but not limited to production volume, product sales, demand and supply assessment and forecast for the period, 2020 - 2028 aim at offering business owners a competitive edge over their rivals. The study further conducts a qualitative evaluation of various driving forces expected to shape the future of the industry during the estimated period.

Quality check and assurance before delivering radiation treatment to a cancer patient is critical in order to maintain the radiation dose as prescribed by the doctor. Some major drivers fueling growth of the global market include enhancement of patient and machine quality assurance in radiation oncology, rising demand for tissue equivalent phantoms, and increasing number of cancer patients globally.

Further Key Findings in the Report:

In November 2020, PTW Freiburg GmbH (PTW) signed a distribution agreement with QRM GmbH. PTW became the sole global distributor of QRM's tissue-equivalent phantoms from to beginning of January 2021.

The Cobalt-60 segment in the global radiation therapy quality assurance (QA) phantoms market is expected to register a CAGR of 4.5% during forecast period. Cobalt-60 is primarily used to maintain the appropriate level of radiation and destroy malignant cells in tumor and cancer treatment.

The market in Europe accounted for second-largest revenue share of 25.0% in 2020. Key factors such as growing focus on medical technology and governmental support are supporting growth of the market in this region.

Key players operating in the market are Computerized Imaging Reference Systems, Inc., Fluke Biomedical, IBA Dosimetry, Modus Medical Devices Inc., PTW Freiburg GmbH, Standard Imaging Inc., Sun Nuclear Corporation, The Phantom Laboratory Inc., Gammex Inc., and Gold Standard Phantoms.

For the purpose of this report, Emergen Research has segmented the global radiation therapy quality assurance (QA) phantoms market based on technology, therapy, application, and region as follows:

Technology Outlook (Revenue: USD Million; 2020–2028)

Linear Accelerators

Cobalt-60

High-Dose Radiation

Low-Dose Radiation

Therapy Outlook (Revenue: USD Million; 2020–2028)

Photon Beam Radiation Therapy

Advanced 3-D Conformal Radiation Therapy

Image Guided Radiation Therapy

Intensity-modulated radiation therapy

Volumetric Modulated Arc Therapy

Intraoperative Radiotherapy

Neutron Beam Therapy

Brachytherapy

Application Outlook (Revenue: USD Million; 2020–2028)

Prostate Cancer

Breast Cancer

Lung Cancer

Colorectal Cancer

Head and Neck Cancers

Skin Cancer

Other

Regional Outlook: (Revenue, USD Billion; 2020-2028)

North America (U.S.) (Canada) (Mexico)

Europe (Germany) (UK) (France) (BENELUX) (Rest of Europe)

Asia Pacific (China) (Japan) (South Korea) (Rest of APAC)

Latin America (Brazil) (Rest of LATAM)

Get a FREE Sample Report@: https://www.emergenresearch.com/request-sample/505

Table of Content
Chapter 1. Methodology Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Radiation Therapy Quality Assurance (QA) Phantoms Market Segmentation Impact Analysis
4.1. Radiation Therapy Quality Assurance (QA) Phantoms Market Segmentation Analysis
4.2. Industrial Outlook
  4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
  4.2.2.1. Increasing demand for tissue equivalent phantoms
  4.2.2.2. Growing concern regarding patient safety
  4.2.3. Market restraints analysis
4.2.3.1. High Cost of phantoms
4.2.3.2. Lack of skilled professionals
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis